BioMarin

BioMarin, established in 1997, is a biopharmaceutical company that markets eight products aimed at treating life-threatening conditions. The company operates in over 70 countries and employs over 3,000 people worldwide. BioMarin offers therapies for achondroplasia, severe hemophilia A, and several rare inherited and lysosomal storage diseases. The company is advancing an industry-leading pipeline of investigational medicines in various stages of clinical and preclinical development. BioMarin is dedicated to manufacturing complex therapies for people who rely on them, with manufacturing facilities located in Novato, California, and Shanbally, Ireland. These sites are certified to ISO 14001 Environment Management Systems and ISO 45001 Occupational Health and Safety Management Systems standards.